Inventor · disambiguated record
Patrick Robert Verhoest
Also filed as: VERHOEST PATRICK · VERHOEST PATRICK R · VERHOEST PATRICK ROBERT
59 granted patents·20 pending applications·371 citations·filing 2002–2024
98Inventor score
Top patents by PatentIndex Score
79 records- 0197US6992087B2Substituted aryl 1,4-pyrazine derivativesPFIZER·Filed 2002·Granted Jan 31, 2006·68 cites·20 claims
- 0294US7041672B2Substituted aryl 1, 4-pyrazine derivativesPFIZER·Filed 2004·Granted May 9, 2006·59 cites·25 claims
- 0393US11452711B2Nitrile-containing antiviral compoundsPFIZER·Filed 2022·Granted Sep 27, 2022·3 cites·8 claims
- 0493US11351149B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jun 7, 2022·6 cites·26 claims
- 0593US7429665B2Heteroaromatic quinoline compoundsPFIZER·Filed 2006·Granted Sep 30, 2008·23 cites·9 claims
- 0691US11541034B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jan 3, 2023·2 cites·30 claims
- 0791US7964607B2Pyrazolo[3,4-d]pyrimidine compoundsPFIZER·Filed 2008·Granted Jun 21, 2011·36 cites·13 claims
- 0890US10039753B2Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitorsPFIZER·Filed 2016·Granted Aug 7, 2018·14 cites·29 claims
- 0990US9845301B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2016·Granted Dec 19, 2017·8 cites·9 claims
- 1089US11472805B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2016·Granted Oct 18, 2022·4 cites·24 claims
- 1189US8598155B2Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disordersHELAL CHRISTOPHER JOHN·Filed 2012·Granted Dec 3, 2013·27 cites·26 claims
- 1288US9598421B2Imidazopyridazine compoundsPFIZER·Filed 2015·Granted Mar 21, 2017·6 cites·24 claims
- 1387US9642855B2Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2015·Granted May 9, 2017·6 cites·10 claims
- 1486US9695171B23,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitorsPFIZER·Filed 2014·Granted Jul 4, 2017·10 cites·7 claims
- 1586US9120788B2Azabenzimidazole compoundsPFIZER·Filed 2014·Granted Sep 1, 2015·8 cites·33 claims
- 1685US9751895B2N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amidesPFIZER·Filed 2016·Granted Sep 5, 2017·3 cites·13 claims
- 1785US9611264B1N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amidesPFIZER·Filed 2016·Granted Apr 4, 2017·7 cites·24 claims
- 1884US2025099424A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 1983US10738063B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2019·Granted Aug 11, 2020·3 cites·16 claims
- 2083US10329308B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2018·Granted Jun 25, 2019·2 cites·23 claims
- 2183US9815832B2Azabenzimidazole compoundsPFIZER·Filed 2015·Granted Nov 14, 2017·4 cites·26 claims
- 2283US9156845B24-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitorsPFIZER·Filed 2013·Granted Oct 13, 2015·6 cites·24 claims
- 2383US8933224B2Triazine derivativesPFIZER·Filed 2014·Granted Jan 13, 2015·5 cites·24 claims
- 2483US8916564B2Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disordersPFIZER·Filed 2013·Granted Dec 23, 2014·6 cites·25 claims
- 2582US10428034B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2017·Granted Oct 1, 2019·3 cites·18 claims
- 2679US10858373B2Heterocyclic spiro compounds as MAGL inhibitorsPFIZER·Filed 2019·Granted Dec 8, 2020·1 cites·17 claims
- 2779US10328082B2Methods of use and combinationsPFIZER·Filed 2015·Granted Jun 25, 2019·4 cites·6 claims
- 2879US7825254B2Heteroaromatic quinoline compoundsPFIZER·Filed 2008·Granted Nov 2, 2010·3 cites·6 claims
- 2978US9296761B2Triazine derivativesPFIZER·Filed 2015·Granted Mar 29, 2016·2 cites·23 claims
- 3078US9145427B2Triazine derivativesPFIZER·Filed 2014·Granted Sep 29, 2015·3 cites·29 claims
- 3177US9200000B2Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disordersPFIZER·Filed 2013·Granted Dec 1, 2015·4 cites·14 claims
- 3276US12049465B2Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Granted Jul 30, 2024·0 cites·10 claims
- 3376US2023120254A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2022·Application pending·0 cites
- 3475US10323042B26,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compoundsPFIZER·Filed 2017·Granted Jun 18, 2019·1 cites·18 claims
- 3575US9328104B2Selective androgen receptor modulatorsPFIZER·Filed 2013·Granted May 3, 2016·4 cites·13 claims
- 3675US8618117B2Amino-heterocyclic compoundsCLAFFEY MICHELLE MARIE·Filed 2012·Granted Dec 31, 2013·3 cites·3 claims
- 3774US10077269B2Imidazopyridazine compoundsPFIZER·Filed 2017·Granted Sep 18, 2018·1 cites·7 claims
- 3874US8278295B2Amino-heterocyclic compoundsCLAFFEY MICHELLE M·Filed 2010·Granted Oct 2, 2012·3 cites·11 claims
- 3974US8183238B2Bicyclic and tricyclic compounds as KAT II inhibitorsCLAFFEY MICHELLE M·Filed 2010·Granted May 22, 2012·5 cites·13 claims
- 4074US7087617B2Substituted pyrimidine derivativesPFIZER·Filed 2004·Granted Aug 8, 2006·6 cites·5 claims
- 4173US2023146535A1Tricyclic compounds and their use as phosphodiesterase inhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 4272US9765073B2Cyclopropabenzofuranyl pyridopyrazinedionesPFIZER·Filed 2016·Granted Sep 19, 2017·1 cites·53 claims
- 4371US9751877B2Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disordersPFIZER·Filed 2015·Granted Sep 5, 2017·1 cites·8 claims
- 4470US9193726B2Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disordersPFIZER·Filed 2014·Granted Nov 24, 2015·1 cites·32 claims
- 4569US10669279B2Imidazopyridazine compoundsPFIZER·Filed 2019·Granted Jun 2, 2020·0 cites·22 claims
- 4669US6964965B2Substituted pyrazine derivativesPHARMACIA & UPJOHN·Filed 2003·Granted Nov 15, 2005·4 cites·24 claims
- 4768US7015229B2Substituted pyrimidinones and pyrimidinthionesPFIZER·Filed 2003·Granted Mar 21, 2006·3 cites·21 claims
- 4867US8933095B2KAT II inhibitorsPFIZER·Filed 2013·Granted Jan 13, 2015·1 cites·20 claims
- 4966US10723711B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2019·Granted Jul 28, 2020·0 cites·18 claims
- 5063US10626125B21,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitorsPFIZER·Filed 2019·Granted Apr 21, 2020·0 cites·23 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Patrick Robert Verhoest files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →